Sage Therapeutics, Inc.

Q3 2024 13F Holders

Symbol
SAGE
CUSIP
78667J108
Type
Equity
Class
COM
Num filers
178
Total reported value, excl. options
$374M
Manager Report Date Value ($000) Shares